SCHEMBL3447635

SCHEMBL3447635

CCCCCCCCCCC(O)C(C(=O)O)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CSNK1E P49674 1/20 0.51
NAAA Q02083 2/20 0.50
CYP2D6 P10635 1/20 0.50
GPR84 Q9NQS5 3/20 0.49
FFAR1 O14842 1/20 0.49
ASAH1 Q13510 2/20 0.48
ALDH1A1 P00352 2/20 0.47
ACER2 Q5QJU3 1/20 0.47
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MAPT P10636 1/20 0.43
LCK P06239 1/20 0.43
PPARD Q03181 1/20 0.43
ZDHHC20 Q5W0Z9 1/20 0.43
ZDHHC2 Q9UIJ5 1/20 0.43
POLB P06746 1/20 0.43
CNR2 P34972 1/20 0.43
CERT1 Q9Y5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9069102 1.00 CSNK1E (0.51) CSNK1ENAAACYP2D6GPR84FFAR1
SCHEMBL9069104 1.00 CSNK1E (0.51) CSNK1ENAAACYP2D6GPR84FFAR1
SCHEMBL16816897 0.86 CYP2D6 (0.57) NAAACYP2D6ALDH1A1POLB
SCHEMBL10538251 0.86 CSNK1E (0.50) CSNK1ENAAACYP2D6GPR84ASAH1
SCHEMBL10443338 0.85 CYP2D6 (0.52) NAAACYP2D6GPR84FFAR1ASAH1
SCHEMBL31447436 0.85 CYP2D6 (0.52) NAAACYP2D6GPR84FFAR1ASAH1
SCHEMBL10443233 0.85 CYP2D6 (0.52) NAAACYP2D6GPR84FFAR1ASAH1
SCHEMBL27501974 0.84 ALDH1A1 (0.50) NAAACYP2D6GPR84FFAR1ASAH1
SCHEMBL31447452 0.83 CYP2D6 (0.48) NAAACYP2D6GPR84FFAR1ASAH1
SCHEMBL28393580 0.82 CYP2D6 (0.52) NAAACYP2D6GPR84FFAR1ASAH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108348906-B Hydrogenation catalyst composition and method for producing same, and hydrogenated polymer and method for producing same 旭化成株式会社 2021-03-30 CN disclosed
EP-3381554-B1 CATALYST COMPOSITION FOR HYDROGENATION, METHOD FOR PRODUCING SAME AND A METHOD FOR PRODUCING HYDROGENATED POLYMER ASAHI CHEMICAL IND (JP) 2021-02-17 EP disclosed
US-20180345261-A1 CATALYST COMPOSITION FOR HYDROGENATION, METHOD FOR PRODUCING SAME, HYDROGENATED POLYMER AND METHOD FOR PRODUCING SAME ASAHI KASEI KABUSHIKI KAISHA (JP) 2018-12-06 US disclosed
US-10144004-B2 Method for producing catalyst composition for hydrogenation and catalyst composition for hydrogenation ASAHI KASEI CHEMICALS CORPORATION (JP) 2018-12-04 US disclosed
EP-3381554-A1 CATALYST COMPOSITION FOR HYDROGENATION, METHOD FOR PRODUCING SAME, HYDROGENATED POLYMER AND METHOD FOR PRODUCING HYDROGENATED POLYMER Asahi Kasei Kabushiki Kaisha (JP) 2018-10-03 EP disclosed
US-10016749-B2 Catalyst composition for hydrogenation and method for hydrogenation using the same ASAHI KASEI CHEMICALS CORPORATION (JP) 2018-07-10 US disclosed
EP-2898949-B1 HYDROGENATION CATALYST COMPOSITION AND HYDROGENATION METHOD USING SAID HYDROGENATION CATALYST COMPOSITION ASAHI CHEMICAL IND (JP) 2018-04-04 EP disclosed
EP-2898950-B1 CATALYST COMPOSITION FOR HYDROGENATION AND HYDROGENATION METHOD USING CATALYST COMPOSITION FOR HYDROGENATION ASAHI CHEMICAL IND (JP) 2017-11-08 EP disclosed
EP-2913348-B1 METHOD OF PRODUCING HYDROGENATION CATALYST COMPOSITION AND HYDROGENATION CATALYST COMPOSITION ASAHI CHEMICAL IND (JP) 2017-09-20 EP disclosed
US-9522393-B2 Catalyst composition for hydrogenation and method for hydrogenation using the same ASAHI KASEI CHEMICALS CORPORATION (JP) 2016-12-20 US disclosed
US-20030022974-A1 Polyvinyl alcohol resin composition and multilayer packages KURARAY CO., LTD. (JP) 2003-01-30 US disclosed
CN-1392889-A Polyvinyl alcohol resin composition and multilayer container KURARAY CO (JP) 2003-01-22 CN disclosed
EP-0473206-B1 Compositions containing a terminal-modified block copolymer ASAHI CHEMICAL IND (JP) 1999-06-23 EP disclosed
EP-0358603-B1 Epoxy resins modified by block polymers and either polyurethanes or polyureas. CIBA GEIGY AG (CH) 1997-12-29 EP disclosed
US-5169905-A Using a bis(cyclopentadienyl)transition metal compound and an alkali aluminum organic complex as catalyst JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1992-12-08 US disclosed
US-5115035-A Modified block copolymer of conjugated diene and vinylaromatic and a tackifier resin ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1992-05-19 US disclosed
EP-0473206-A2 Compositions containing a terminal-modified block copolymer Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1992-03-04 EP disclosed
EP-0358603-A2 Epoxy resins modified by block polymers CIBA-GEIGY AG (CH) 1990-03-14 EP disclosed
EP-0245505-A1 TERMINAL-MODIFIED BLOCK COPOLYMER AND COMPOSITION CONTAINING SAID COPOLYMER Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1987-11-19 EP disclosed
US-4603171-A ANTIONIC CATALYSTS PHILLIPS PETROLEUM COMPANY (US) 1986-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10016749-B2 Catalyst composition for hydrogenation and method for hydrogenation using the same H1-0, H1-2, HVCN1 CSNK1E 1071/4885NAAA 610/4885CYP2D6 2012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.